| Literature DB >> 21816081 |
Susan B Altenbach1, Frances M Dupont1, Charlene K Tanaka1, William J Hurkman1, Linda C Whitehand1, William H Vensel1.
Abstract
BACKGROUND: Mineral nutrition during wheat grain development has large effects on wheat flour protein content and composition, which in turn affect flour quality and immunogenic potential for a commodity of great economic value. However, it has been difficult to define the precise effects of mineral nutrition on protein composition because of the complexity of the wheat flour proteome. Recent improvements in the identification of flour proteins by tandem mass spectrometry (MS/MS) and the availability of a comprehensive proteome map of flour from the US wheat Butte 86 now make it possible to document changes in the proportions of individual flour proteins that result from the application of mineral nutrition.Entities:
Year: 2011 PMID: 21816081 PMCID: PMC3168407 DOI: 10.1186/1477-5956-9-46
Source DB: PubMed Journal: Proteome Sci ISSN: 1477-5956 Impact factor: 2.480
Effect of PAF on grain yield, flour properties and CNS composition
| Bushel Weight (kg) | 61.0 +/- 0.3 | 63.0 +/- 0.4 | 3.3* |
| Flour Yield (% dry weight) | 67.5 +/- 1.2 | 68.8 +/- 0.6 | 1.9 |
| Flour Moisture (%) | 13.8 +/- 0.0 | 14.2 +/- 0.2 | 2.9 |
| Flour Protein (%) | 7.0 +/- 0.4 | 14.0 +/- 0.9 | 100.0* |
| Mix Time (min) | 2.8 +/- 0.6 | 2.2 +/- 0.3 | -21.4 |
| Mix Tolerance3,4 | 2.3 +/- 0.6 | 3.7 +/- 0.6 | 60.9 |
| Loaf Volume (ml)3 | 51.7 +/- 1.5 | 82.0 +/- 3.5 | 58.6* |
| % C | 39.6 +/- 0.1 | 40.1 +/- 0.1 | 1.3 |
| % N | 1.27 +/- 0.06 | 2.50 +/- 0.15 | 96.9* |
| % S | 0.12 +/- 0.00 | 0.17 +/- 0.01 | 41.7* |
| N:S | 10.6 +/- 0.03 | 14.7 +/- 0.04 | 38.7* |
1 Mean and standard deviation from flour samples from three biological replicates.
2 * indicates that change was significant, p < 0.02.
3 Determined using 10 g flour samples.
4 Recorded on a 1-4 scale with 4 having the greatest tolerance.
Figure 1Effect of post-anthesis fertilizer (PAF) on accumulation levels of individual wheat flour proteins. Flour proteins from plants grown without (A) or with (B) PAF were analyzed by 2-DE. Boxes in B indicate protein classes that are depicted in panels C-K. The spots indicated in panel A fall outside the perimeters of the selected areas in panel B. The green and red numbers indicate spots that significantly increased or decreased, respectively, and the black numbers indicate spots that did not change with PAF. Spots containing the large subunits of triticin are indicated in panels Ia and the small subunits in Ib. Asterisks in panel J designate spots containing purinins. Protein sequences associated with spots that increased or decreased significantly are listed in Tables 2 and 3. The identities of the proteins that did not change significantly are listed in Additional file 1.
2-DE spots that increased significantly with PAF
| Spot Number | |
|---|---|
| 60 | Omega-gliadin |
| 63 | Omega-gliadin |
| 71 | Omega-gliadin |
| 74 | Omega-gliadin |
| 69 | Omega-gliadin |
| 73 | Omega-gliadin |
| 107 | Omega-gliadin Cys type TC_2627702 |
| 113 | Omega-gliadin Cys type TC_2627704 |
| 115 | Omega-gliadin Cys type TC_2627704 |
| 135 | Omega-gliadin Gli-A3 Bu-D52 |
| 391 | Omega-gliadin Gli-A3 Bu-D55 |
| 476 | Omega-gliadin |
| 477 | Omega-gliadin |
| 12 | HMW-GS Ax2* [GenBank: |
| 17 | HMW-GS Ax2* [GenBank: |
| 19 | HMW-GS Ax2* [GenBank: |
| 20 | HMW-GS Bx7 [GenBank: |
| 21 | HMW-GS Bx7 [GenBank: |
| 302 | HMW-GS Bx7 [GenBank: |
| 350 | HMW-GS 1By9 [GenBank: |
| 3 | HMW-GS Dx5 [GenBank: |
| 7 | HMW-GS Dx5 [GenBank: |
| 10 | HMW-GS Dx5 [GenBank: |
| 42 | HMWGS Dy10 [GenBank: |
| 342 | Alpha-gliadin Bu-15,6 |
| 468 | Alpha-gliadin Bu-35,6 |
| 467 | Alpha-gliadin Bu-45,6 |
| 327 | Alpha-gliadin Bu-115 |
| 387 | Alpha-gliadin Bu-125 |
| 524 | Alpha-gliadin Bu-125 |
| 190 | Alpha-gliadin Bu-144 |
| 124 | Alpha-gliadin Bu-BQ8071302,6 |
| 148 | Serpin Bu-12 |
| 149 | Serpin Bu-25 |
| 397 | Serpin Bu-22 |
| 398 | Serpin Bu-32 |
| 399 | Serpin Bu-32 |
| 159 | Serpin Bu-44,6 |
| 151 | Serpin Bu-52 |
| 167 | LMW-GS Bu-15 |
| 131 | LMW-GS Bu-32 |
| 317 | LMW-GS Bu-2/134 |
| 318 | LMW-GS Bu-2/135 |
| 155 | LMW-GS Bu-185 |
| 325 | Gamma-gliadin Bu-1or Bu-85,7 |
| 334 | Gliadin, mixed spot8 |
| 348 | Triticin TC11_2855585 |
| 176 | Malate dehydrogenase [GenBank: |
1 Identifications are from Dupont et al. [28].
2 MS/MS analysis in [28] indicated that spot contained only one protein.
3 No peptides identified by MS/MS in [28]. Spot identified in [43].
4 Predominant protein identified by MS/MS in [28]. Analysis indicated that spot also contained other proteins from the same class.
5 Predominant protein identified by MS/MS in [28]. Analysis indicated that spot also contained proteins from a different class.
6 Predominant protein sequence identified in only one spot.
7 MS/MS data in [28] was not sufficient to discriminate among proteins.
8 More than one protein was identified in spot in [28], but no one protein was predominant.
Individual 2-DE spots that decreased significantly with PAF
| Spot Number | |
|---|---|
| 289 | Alpha-amylase inhibitor WMAI [PRF:223520]2 |
| 528 | Alpha-amylase inhibitor WMAI [PRF:223520]2 |
| 283 | Alpha-amylase inhibitor WDAI TC11_3385243,4 |
| 286 | Alpha-amylase inhibitor WDAI [GenBank: |
| 312 | Alpha-amylase inhibitor WDAI [SwissProt: |
| 313 | Alpha-amylase inhibitor WTAI-CM1 TC11_3405104,5 |
| 280 | Alpha-amylase inhibitor WTAI-CM2 [SwissProt: |
| 285 | Alpha-amylase inhibitor WTAI-CM2 [SwissProt: |
| 264 | Alpha-amylase inhibitor WTAI-CM3 [SwissProt: |
| 265 | Alpha-amylase inhibitor WTAI-CM3 [SwissProt: |
| 266 | Alpha-amylase inhibitor WTAI-CM16 [SwissProt: |
| 284 | Alpha-amylase inhibitor WTAI-CM16 [SwissProt: |
| 274 | Alpha-amylase inhibitor WTAI-CM17 [GenBank: |
| 282 | Alpha-amylase inhibitor WTAI-CM17 [GenBank: |
| 244 | Alpha-amylase/subtilisin inhibitor WASI [SwissProt: |
| 281 | Protease inhibitor CMx1/CMx3 TC11_3093983,4 |
| 290 | Protease inhibitor CMx1/CMx3 TC11_3081463,4 |
| 277 | Chymotrypsin inhibitor WCI [GenBank: |
| 278 | Chymotrypsin inhibitor WCI, mixed spot6 |
| 170 | LMW-GS Bu-15 |
| 119 | LMW-GS Bu-32 |
| 161 | LMW-GS Bu-35 |
| 237 | LMW-GS Bu-32 |
| 316 | LMW-GS Bu-35 |
| 140 | LMW-GS Bu-42 |
| 173 | LMW-GS Bu-64,5 |
| 145 | LMW-GS Bu-73 |
| 203 | LMW-GS Bu-115 |
| 315 | LMW-GS Bu-113 |
| 153 | LMW-GS Bu-182 |
| 326 | Gamma-gliadin Bu-14,5 |
| 166 | Gamma-gliadin Bu45 |
| 134 | Gamma-gliadin Bu-55 |
| 323 | Gamma-gliadin Bu-55 |
| 335 | Gamma-gliadin Bu-65 |
| 527 | Gamma-gliadin Bu-115 |
| 385 | Farinin Bu-12 |
| 193 | Farinin Bu-25 |
| 207 | Farinin Bu-22 |
| 549 | Farinin Bu-22 |
| 336 | Farinin Bu-35 |
| 345 | Farinin Bu-35 |
| 542 | Purinin Bu-15 |
| 543 | Purinin Bu-15 |
| 219 | Purinin Bu-22 |
| 223 | Purinin Bu-22 |
| 220 | Purinin Bu-32 |
| 227 | Purinin Bu-32 |
| 99 | Globulin-2 Bu-173662,4 |
| 104 | Globulin-2 Bu-172952 |
| 106 | Globulin-2 Bu-184282 |
| 184 | Globulin Glo-3 TC11_3053893 |
| 272 | Globulin Glo-3 TC_2340945 |
| 14 | HMW-GS Dx5 [GenBank: |
| 538 | HMW-GS Dx5 [GenBank: |
| 25 | HMW-GS Bx7 [GenBank: |
| 33 | HMW-GS Bx7 [GenBank: |
| 514 | HMWGS Dy10 [GenBank: |
| 94 | Beta-amylase Bu-23 |
| 93 | Beta-amylase Bu-33 |
| 232 | Chitinase [GenBank: |
| 455 | Chitinase [GenBank: |
| 248 | Puroindoline-b [GenBank: |
| 271 | Puroindoline-b [GenBank: |
| 89 | ADP glucose pyrophosphorylase, large subunit [GenBank: |
| 295 | Lipid transfer protein (LTP) Bu-22,4 |
| 456 | Thaumatin-like protein TC11_2831362,4 |
| 225 | Triose phosphate isomerase [GenBank: |
| 311 | Elongation factor EF1A [SwissProt: |
| 202 | Glucose and ribitol dehydrogenase RS_UWI_149032,4 |
| 195 | Gliadin, mixed spot6 |
1 Identifications are from Dupont et al. [28].
2 MS/MS analysis in Dupont et al. [28] indicated that spot contained only one protein.
3 Predominant protein identified by MS/MS in Dupont et al. [28]. Analysis indicated that spot also contained other proteins from the same class.
4 Predominant protein sequence identified in only one spot.
5 Predominant protein identified by MS/MS in [28]. Analysis indicated that spot also contained proteins from a different class.
6 More than one protein was identified in spot, but no one protein was predominant.
Unique proteins that changed significantly with PAF
| Spot Volume | |||||
|---|---|---|---|---|---|
| # Spots | -PAF | +PAF | % Change | ||
| Omega-gliadin | 6 | 60+, 63+, 69+,71+, 73+, 74+ | 1.940 | 5.070 | 161.4 |
| Omega-gliadin | 2 | 476+, 477+ | 1.413 | 3.059 | 116.5 |
| Omega-gliadin Bu-D5 | 2 | 135+, 391+ | 0.392 | 0.985 | 151.4 |
| Omega-gliadin Cys type TC_262770 | 4 | 107+, 113+, 115+, 116 | 0.502 | 1.248 | 148.4 |
| HMW-GS Ax2* [GenBank: | 8 | 12+, 16, 17+, 18, 19+, 23, 24, 28 | 1.719 | 2.411 | 40.2 |
| HMW-GS Bx7 [GenBank: | 8 | 20+, 21+, 25-, 26, 27, 29, 33-, 302+ | 3.885 | 5.019 | 29.2 |
| HMW-GS Dx5 [GenBank: | 9 | 3+, 5, 7+, 10+, 14-, 36, 138, 307, 538- | 2.691 | 3.732 | 38.7 |
| HMW-GS 1By9 [GenBank: | 8 | 40, 47, 52, 358, 349, 350+, 351, 360 | 1.478 | 2.277 | 54.0 |
| HMWGS Dy10 [GenBank: | 7 | 42+, 48, 51, 333, 407, 424, 514- | 3.100 | 3.675 | 18.6 |
| Alpha-gliadin Bu-1 | 1 | 342+ | 0.516 | 0.845 | 63.8 |
| Alpha-gliadin Bu-3 | 1 | 468+ | 1.219 | 1.658 | 36.0 |
| Alpha-gliadin Bu-4 | 1 | 467+ | 1.296 | 2.006 | 54.7 |
| Alpha-gliadin Bu-12 | 5 | 328, 329, 387+, 524+, 525 | 1.903 | 3.063 | 60.9 |
| Alpha-gliadin Bu-14 | 4 | 331, 190+, 206, 546 | 0.821 | 1.094 | 33.2 |
| Alpha-gliadin Bu-BQ807130 | 1 | 124+ | 0.188 | 0.287 | 52.6 |
| Serpin Bu-1 | 3 | 146, 147, 148+ | 0.461 | 0.599 | 30.1 |
| Serpin Bu-1 or Bu-4 | 2 | 158, 162 | 0.069 | 0.040 | -41.3 |
| Serpin Bu-2 | 2 | 149+, 397+ | 0.067 | 0.193 | 188.6 |
| Serpin Bu-3 | 2 | 398+, 399+ | 0.038 | 0.087 | 126.1 |
| Serpin Bu-4 | 1 | 159+ | 0.146 | 0.236 | 62.2 |
| Serpin Bu-5 | 2 | 151+, 154 | 0.181 | 0.268 | 48.5 |
| Alpha-amylase inhibitor WMAI [PRF:223520] | 2 | 289-, 528- | 1.043 | 0.492 | -52.9 |
| Alpha-amylase inhibitor WDAI TC11_338524 | 1 | 283- | 0.357 | 0.216 | -39.6 |
| Alpha-amylase inhibitor WDAI [GenBank: | 1 | 286- | 0.274 | 0.115 | -57.9 |
| Alpha-amylase inhibitor WDAI [SwissProt: | 1 | 312- | 1.305 | 0.671 | -48.6 |
| Alpha-amylase inhibitor WTAI-CM1 TC11_340510 | 1 | 313- | 0.557 | 0.210 | -62.3 |
| Alpha-amylase inhibitor WTAI-CM2 [Swiss-Prot: | 2 | 285-, 280- | 1.377 | 0.479 | -65.2 |
| Alpha-amylase inhibitor WTAI-CM3 [Swiss-Prot: | 2 | 264-, 265- | 1.409 | 0.495 | -64.9 |
| Alpha-amylase inhibitor WTAI-CM16 [Swiss-Prot: | 2 | 266-, 284- | 1.235 | 0.512 | -58.6 |
| Alpha-amylase inhibitor WTAI-CM17 [Genbank: | 2 | 274-, 282- | 0.634 | 0.217 | -65.8 |
| Alpha-amylase/subtilisin inhibitor WASI [SwissProt: | 1 | 244- | 0.264 | 0.171 | -35.0 |
| Protease inhibitor CMx1/CMx3 TC11_309398 | 1 | 281- | 0.361 | 0.229 | -36.5 |
| Protease inhibitor CMx1/CMx3 TC11_308146 | 1 | 290- | 0.074 | 0.028 | -62.8 |
| Chymotrypsin inhibitor WCI [GenBank: | 1 | 277- | 0.327 | 0.116 | -64.7 |
| Farinin Bu-1 | 3 | 196, 385-, 386 | 0.358 | 0.246 | -31.2 |
| Farinin Bu-2 | 3 | 193-, 207-, 549- | 1.271 | 0.325 | -74.4 |
| Farinin Bu-3 | 2 | 336-, 345- | 0.815 | 0.336 | -58.7 |
| Purinin Bu-1 | 2 | 542-, 543- | 0.487 | 0.294 | -39.7 |
| Purinin Bu-2 | 2 | 219-, 223- | 0.524 | 0.261 | -50.2 |
| Purinin Bu-3 | 2 | 220-, 227- | 0.491 | 0.270 | -45.0 |
| LMW-GS Bu-3 | 9 | 119-, 119a, 120, 131+, 132, 161-, 237-, 310, 316- | 8.015 | 6.062 | -24.4 |
| LMW-GS Bu-6 | 1 | 173- | 0.634 | 0.471 | -25.7 |
| LMW-GS Bu-7 | 3 | 144, 145-, 472 | 3.320 | 2.473 | -25.5 |
| Gamma-gliadin Bu-1 | 1 | 326- | 0.191 | 0.132 | -30.9 |
| Globulin-2 Bu-18428 | 2 | 103, 106- | 0.129 | 0.088 | -31.6 |
| Globulin-2 Bu-17366 | 1 | 99 | 0.043 | 0.028 | -34.1 |
| Chitinase [GenBank: | 1 | 232- | 0.095 | 0.041 | -56.8 |
| Chitinase [GenBank: | 1 | 455- | 0.125 | 0.047 | -62.3 |
| Puroindoline b [Genbank: | 2 | 248-, 271- | 0.512 | 0.251 | -51.0 |
| Beta-amylase Bu-2 | 2 | 94-, 462 | 0.231 | 0.145 | -37.4 |
| Lipid transfer protein (LTP) Bu-2 | 1 | 295- | 0.117 | 0.035 | -69.8 |
| Thaumatin-like protein TC11_283136 | 1 | 456- | 0.095 | 0.049 | -48.4 |
| Triose phosphate isomerase [GenBank: | 1 | 225- | 0.081 | 0.046 | -42.6 |
| Elongation factor EF1A [SwissProt: | 1 | 311- | 0.168 | 0.113 | -32.7 |
| Glucose and ribitol dehydrogenase RS_UWI_14903 | 1 | 202- | 0.117 | 0.004 | -96.6 |
1 Identifications are from Dupont et al. [28].
2 Spots that increased or decreased significantly (p < 0.02) are indicated with + and -, respectively.
3 Includes proteins identified as TC11_288652.
4 Includes protein identified as [GenBank:AAT74547].
Summary of changes in protein classes with PAF
| Total Spot Volume | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Total # Spots | -PAF | +PAF | -PAF | +PAF | % Change | ||||
| HMW-GS | 40 | 16 | 5 | 12.87 | 17.11 | 32.9* | 9.01 | 23.96 | 165.9 |
| LMW-GS5 | 29 | 16 | 3 | 21.11 | 17.93 | -15.1* | 14.78 | 25.11 | 68.9 |
| Alpha-gliadins6 | 22 | 8 | 6 | 15.58 | 20.41 | 31.0* | 10.90 | 28.56 | 162.1 |
| Gamma-gliadins6 | 16 | 7 | 1 | 12.82 | 12.10 | -5.6 | 8.98 | 16.95 | 87.8 |
| Omega-gliadins6 | 15 | 13 | 4 | 4.28 | 10.44 | 143.9* | 3.00 | 14.62 | 387.8 |
| Gliadin mixed spots6,7 | 5 | 2 | n/a | 2.12 | 2.56 | 20.3 | 1.49 | 3.58 | 140.7 |
| Globulins | 10 | 5 | 2 | 0.54 | 0.38 | -30.4 | 0.38 | 0.53 | 39.2 |
| Farinins | 8 | 6 | 3 | 2.44 | 0.91 | -62.9* | 1.71 | 1.27 | -25.7 |
| Purinins | 6 | 6 | 3 | 1.50 | 0.82 | -45.1* | 1.05 | 1.15 | 9.9 |
| Triticins | 7 | 1 | 0 | 1.35 | 1.50 | 10.9 | 0.95 | 2.10 | 121.9 |
| GSPs and puroindolines | 4 | 2 | 1 | 0.64 | 0.33 | -49.0* | 0.45 | 0.46 | 2.0 |
| Serpins | 14 | 7 | 5 | 1.15 | 1.58 | 37.4* | 0.81 | 2.22 | 174.8 |
| Amylase/protease inhibitors | 19 | 19 | 13 | 9.55 | 4.09 | -57.2* | 6.69 | 5.73 | -14.3 |
| Other inhibitors | 2 | 0 | 0 | 0.34 | 0.26 | -24.2 | 0.24 | 0.37 | 51.6 |
| Beta-amylase | 6 | 2 | 1 | 0.66 | 0.50 | -25.0* | 0.46 | 0.70 | 49.9 |
| Other enzymes | 23 | 6 | 4 | 2.13 | 1.52 | -28.8* | 1.49 | 2.13 | 42.5 |
| Other miscellaneous | 5 | 3 | 3 | 0.55 | 0.34 | -38.9 | 0.38 | 0.47 | 22.2 |
| No ID | 142 | 36 | n/a | 7.28 | 4.95 | -58.3* | 5.10 | 6.94 | 36.1 |
1 Total protein was 70 μg/mg flour for -PAF and 140 μg/mg flour for +PAF; protein amount was calculated as (spot volume)*(total μg/mg flour)/100.
2 Significant change, p < 0.02.
3 n/a indicates not applicable.
4 * indicates that overall change with PAF is significant (p < 0.02).
5 LMW-GSs include only those with classic LMW-GS sequences.
6 Gliadins include those with odd numbers of Cys that might be incorporated into the glutenin polymer.
7 Spot contained a mixture of different proteins, but no one sequence was predominant.
Figure 2Percentage change in absolute protein amount for protein types with different contents of Cys plus Met. The content of S-containing amino acids was determined for each protein type (Additional file 4). Proteins containing low S are indicated in blue, low to medium S in green, medium S in orange and high S in red.